{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:55:19Z","timestamp":1781585719149,"version":"3.54.5"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    The escalating global prevalence of carbapenem-resistant Gram-negative bacteria has significantly constrained therapeutic options, leading to the revived use of polymyxins. However, this resurgence has been paralleled by an increase in reports of associated adverse effects. No case of drug fever induced by polymyxin B (PMB) has been reported in the literature to date. We report the first case of drug fever (\u226539\u00a0\u00b0C) induced by intravenous PMB in a patient with severe pneumonia caused by carbapenem-resistant\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    , accompanied by tachypnea following concomitant nebulized PMB administration. Upon intervention by the clinical pharmacist, which involved discontinuation of PMB and adjustment of the anti-infective regimen, the patient\u2019s fever resolved promptly and the infection was successfully controlled. This case highlights a severe and previously unreported adverse drug reaction to PMB, underscoring the necessity for vigilant monitoring and proactive antimicrobial stewardship in managing infections.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1812802","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:27:36Z","timestamp":1781584056000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["First case report of polymyxin B-induced drug fever in a patient with carbapenem-resistant Acinetobacter baumannii pneumonia"],"prefix":"10.3389","volume":"17","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Basic Medical Science, Chongqing Three Gorges Medical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Xing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Min","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20420986251335825","DOI":"10.1177\/20420986251335825","article-title":"Drug-induced fever in post-surgical patients: a systematic review of case reports","volume":"16","author":"Afra","year":"2025","journal-title":"Ther. Adv. Drug Saf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1163341","DOI":"10.3389\/fcimb.2023.1163341","article-title":"Case report: a case of spinal muscular atrophy with extensively drug-resistant Acinetobacter baumannii pneumonia treated with nebulization combined with intravenous polymyxin B: experience and a literature review","volume":"13","author":"Cao","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/antibiotics9100719","article-title":"Relationship between virulence and resistance among gram-negative bacteria","volume":"9","author":"Cepas","year":"2020","journal-title":"Antibiot. (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.11655\/zgywylc2025.20.007","article-title":"Adverse drug reactions induced by polymyxin B: a systematic review of the global literature","volume":"20","author":"Chen","year":"2025","journal-title":"Chin. Remedies Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1342419","DOI":"10.3389\/fneur.2024.1342419","article-title":"Polymyxin-induced neuromuscular weakness: a case report","volume":"15","author":"Chin","year":"2024","journal-title":"Front. Neurol."},{"key":"B7","article-title":"Surveillance of bacterial resistance in China: 2025 first-half report","year":"2025"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1093\/jac\/dkv014","article-title":"Risk factors for nephrotoxicity onset associated with polymyxin B therapy","volume":"70","author":"Dubrovskaya","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.7326\/0003-4819-74-1-143","article-title":"Adverse effects of sodium colistimethate","volume":"74","author":"Flanagan","year":"1971","journal-title":"Ann. Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.11604\/pamj.2024.47.43.37617","article-title":"A comparative study on the use of procalcitonin to distinguish between central fever and infectious causes of fever","volume":"47","author":"Khanum","year":"2024","journal-title":"Pan Afr. Med. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1594127","DOI":"10.3389\/fphar.2025.1594127","article-title":"Case report: polymyxin B-induced anaphylactic shock","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B13","first-page":"104","article-title":"Antibiotics and endotoxic shock","volume-title":"Infectious Disease Workshop. Seminar on Gram-Negative Infections. Washington University School of Medicine","author":"McCabe","year":"1973"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e22924","DOI":"10.1097\/MD.0000000000022924","article-title":"Polymyxin B-induced rhabdomyolysis: a case report","volume":"99","author":"Ni","year":"2020","journal-title":"Med. Baltim."},{"key":"B15","doi-asserted-by":"publisher","first-page":"963140","DOI":"10.3389\/fphar.2022.963140","article-title":"Case report: respiratory paralysis associated with polymyxin B therapy","volume":"13","author":"Ning","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2169\/internalmedicine.2322-23","article-title":"Prevalence of drug fever among cases of nosocomial fever: a systematic review and meta-analysis","volume":"63","author":"Someko","year":"2024","journal-title":"Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1097\/MS9.0000000000002699","article-title":"Polymyxin-B induced Bartter-like syndrome: an unusual adverse effect","volume":"86","author":"Taik","year":"2024","journal-title":"Ann. Med. Surg. (Lond)."},{"key":"B18","doi-asserted-by":"publisher","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"7","author":"Tamma","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/s0014-5793(99)00150-7","article-title":"Kinetics of the interaction of endotoxin with polymyxin B and its analogs: a surface plasmon resonance analysis","volume":"445","author":"Thomas","year":"1999","journal-title":"FEBS Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1378\/chest.79.2.237","article-title":"Acute respiratory failure secondary to polymyxin-B inhalation","volume":"60","author":"Wilson","year":"1971","journal-title":"Chest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jinf.2016.11.015","article-title":"Clinical translation of polymyxin-based combination therapy: facts, challenges and future opportunities","volume":"74","author":"Zhang","year":"2017","journal-title":"J. Infect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"107427","DOI":"10.1016\/j.ijantimicag.2024.107427","article-title":"Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: a prospective multicenter cohort study","volume":"65","author":"Zhang","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jac\/dkw377","article-title":"Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis","volume":"72","author":"Zusman","year":"2017","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1812802\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:27:41Z","timestamp":1781584061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1812802\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":23,"alternative-id":["10.3389\/fphar.2026.1812802"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1812802","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"article-number":"1812802"}}